Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00625651

Public ClinicalTrials.gov record NCT00625651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2 Study of AMG 655 in Combination With Modified FOLFOX6 and Bevacizumab for the First-Line Treatment of Subjects With Metastatic Colorectal Cancer

Study identification

NCT ID
NCT00625651
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Amgen
Industry
Enrollment
202 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • AMG 655 Drug
  • Modified FOLFOX6 Drug
  • Bevacizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Jul 31, 2010
Completion
Aug 31, 2011
Last update posted
Apr 24, 2014

2007 – 2011

United States locations

U.S. sites
61
U.S. states
30
U.S. cities
59
Facility City State ZIP Site status
Research Site Hot Springs Arkansas 71913
Research Site Downey California 90241
Research Site La Jolla California 92093-0957
Research Site Loma Linda California 92354
Research Site Orange California 92868
Research Site Rancho Mirage California 92270
Research Site San Diego California 92123
Research Site Denver Colorado 80218
Research Site Newark Delaware 19718
Research Site Washington D.C. District of Columbia 20007
Research Site Boca Raton Florida 33486
Research Site Kissimmee Florida 34741
Research Site Leesburg Florida 34788
Research Site Miami Florida 33136
Research Site Miami Florida 33176
Research Site Atlanta Georgia 30309
Research Site Lawrenceville Georgia 30045
Research Site Harvey Illinois 60426
Research Site Maywood Illinois 60153
Research Site Indianapolis Indiana 46227
Research Site Overland Park Kansas 66210
Research Site Louisville Kentucky 40202
Research Site Baltimore Maryland 21215
Research Site Baltimore Maryland 21237
Research Site Boston Massachusetts 02115
Research Site Ann Arbor Michigan 48106-0995
Research Site Saint Joseph Michigan 49085
Research Site Rochester Minnesota 55905
Research Site St Louis Missouri 63136
Research Site Great Falls Montana 59405
Research Site Long Branch New Jersey 07740
Research Site Albuquerque New Mexico 87109-4397
Research Site Buffalo New York 14263
Research Site Hudson New York 12534
Research Site New York New York 10021
Research Site The Bronx New York 10469
Research Site Asheville North Carolina 28801
Research Site Burlington North Carolina 27215
Research Site Gastonia North Carolina 28054
Research Site Raleigh North Carolina 27607
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45226
Research Site Columbus Ohio 43219
Research Site Middletown Ohio 45042
Research Site Portland Oregon 97227
Research Site Harrisburg Pennsylvania 17109
Research Site Philadelphia Pennsylvania 19107
Research Site Pottsville Pennsylvania 17901
Research Site Greenville South Carolina 29605
Research Site Memphis Tennessee 38120
Research Site Nashville Tennessee 37203
Research Site Austin Texas 78731
Research Site Richardson Texas 75080
Research Site Tyler Texas 75702
Research Site Wichita Falls Texas 76310
Research Site Ogden Utah 84403
Research Site Fairfax Virginia 22031
Research Site Norfolk Virginia 23502
Research Site Richmond Virginia 23235
Research Site Tacoma Washington 98405
Research Site Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00625651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00625651 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →